Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-18
2010-02-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S374000, C548S236000
Reexamination Certificate
active
07662771
ABSTRACT:
The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.
REFERENCES:
patent: 3578671 (1971-05-01), Brown
patent: 4239754 (1980-12-01), Sache et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5643957 (1997-07-01), Leone-Bay et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
patent: 5693338 (1997-12-01), Milstein
patent: 5820881 (1998-10-01), Milstein
patent: 5866536 (1999-02-01), Leone-Bay et al.
patent: 5955503 (1999-09-01), Leone-Bay et al.
patent: 5965121 (1999-10-01), Ho et al.
patent: 5976569 (1999-11-01), Milstein
patent: 5989539 (1999-11-01), Leone-Bay et al.
patent: 6001347 (1999-12-01), Leone-Bay et al.
patent: 6071510 (2000-06-01), Leone-Bay et al.
patent: 6100298 (2000-08-01), Leone-Bay et al.
patent: 6242495 (2001-06-01), Leone-Bay et al.
patent: WO 00/40203 (2000-07-01), None
patent: WO 00/47188 (2000-08-01), None
patent: WO 00/50386 (2000-08-01), None
patent: WO 00/59863 (2000-10-01), None
patent: WO 01/32130 (2001-05-01), None
patent: WO 01/44199 (2001-06-01), None
patent: WO 01/51454 (2001-07-01), None
patent: WO 02/02509 (2002-01-01), None
patent: WO 03/072195 (2003-09-01), None
patent: WO 2005/000339 (2005-01-01), None
Hinegardner et al., The Synthesis of Thiazole Amines Possessing Pharmacological Interest, 1930, Journal of the American Chemical Society, 52, p. 4140.
Dai, Y. et al. “A Novel Series of Histone Deacetylase Inhibitors Incorporating Hetero Aromatic Ring Systems as Connection Units.” Science Direct, Bioorganic and Medicinal Chemistry Letters 13, pp. 3817-3820, 2003.
Patel, H. et al. “Oral Administration of Insulin By Encapsulation Within Liposomes.” FEBS Letters, vol. 62, No. 1, pp. 60-63, 1976.
Hashimoto, A. et al. “Effects of Oral Administration of Positively Charged Insulin Liposomes on Alloxan Diabetic Rats: Preliminary Study.” Endocrinology Japan, vol. 26, No. 3, pp. 337-344, 1979.
Herr Robert Jason
Jungheim Louis Nickolaus
McGill, III John McNeill
Thrasher Kenneth Jeff
Valluri Muralikrishna
Bianchi Kristin
Emisphere Technologies Inc.
Kaplan Gilman & Pergament LLP
Saeed Kamal A
LandOfFree
Compounds, methods and formulations for the oral delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, methods and formulations for the oral delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, methods and formulations for the oral delivery of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4166799